Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Siga acquires Chlamydia vaccine technology from Oregon State University

March 27, 2000

Vasogen cleared to proceed with clinical trial of VAS-981 in leukemia patients

March 24, 2000

IND filed with FDA for ISAtx-247

March 23, 2000

Effects of TAK-603 on cytokine production reported at Japanese congress

March 22, 2000

Medinox's NO neutralizer prevents transplant rejection in preclinical study

March 21, 2000

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

March 20, 2000

SangStat files NDA in Canada for Thymoglobulin

March 17, 2000

Isotechnika receives Canadian approval for human testing of immunosuppressive drug

March 16, 2000

3M's new immunomodulators induce TNF-alpha, IFN-alpha biosynthesis, inhibit Th2 immune response

March 15, 2000

Dynavax's ragweed immunotherapy has improved safety according to preclinical and clinical data

March 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...